A broad and potent neutralization epitope in SARS-related coronaviruses

Yuan, Meng; Zhu, Xueyong; He, Wan-ting; Zhou, Panpan; Kaku, Chengzi I.; Capozzola, Tazio; Zhu, Connie Y.; Yu, Xinye; Liu, Hejun; Yu, Wenli; Hua, Yuanzi; Tien, Henry; Peng, Linghang; Song, Ge; Cottrell, Christopher A.; Schief, William R.; Nemazee, David; Walker, Laura M.; Andrabi, Raiees; Burton, Dennis R.; Wilson, Ian A.

doi:10.1073/pnas.2205784119

A broad and potent neutralization epitope in SARS-related coronaviruses

Journal Article · 01 June 2022 · Proc. Natl. Acad. Sci. USA

DOI:https://doi.org/10.1073/pnas.2205784119· OSTI ID:1901026

Yuan, Meng; Zhu, Xueyong; He, Wan-ting; Zhou, Panpan; Kaku, Chengzi I.; Capozzola, Tazio; Zhu, Connie Y.; Yu, Xinye; Liu, Hejun; Yu, Wenli; Hua, Yuanzi; Tien, Henry; Peng, Linghang; Song, Ge; Cottrell, Christopher A.; Schief, William R.; Nemazee, David; Walker, Laura M.; Andrabi, Raiees; Burton, Dennis R. more »

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY; OTHER

OSTI ID:: 1901026

Journal Information:: Proc. Natl. Acad. Sci. USA, Journal Name: Proc. Natl. Acad. Sci. USA Journal Issue: (29) Vol. 119

Country of Publication:: United States

Language:: ENGLISH

References (52)

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Lan, Jun; Ge, Jiwan; Yu, Jinfang Nature, Vol. 581, Issue 7807 https://doi.org/10.1038/s41586-020-2180-5	journal	March 2020
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies VanBlargan, Laura A.; Errico, John M.; Halfmann, Peter J. Nature Medicine, Vol. 28, Issue 3 https://doi.org/10.1038/s41591-021-01678-y	journal	January 2022
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Pinto, Dora; Park, Young-Jun; Beltramello, Martina Nature, Vol. 583, Issue 7815 https://doi.org/10.1038/s41586-020-2349-y	journal	May 2020
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies Yuan, Meng; Liu, Hejun; Wu, Nicholas C. Biochemical and Biophysical Research Communications, Vol. 538 https://doi.org/10.1016/j.bbrc.2020.10.012	journal	January 2021
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain Wu, Nicholas C.; Yuan, Meng; Liu, Hejun Cell Reports, Vol. 33, Issue 3 https://doi.org/10.1016/j.celrep.2020.108274	journal	October 2020
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice Martinez, David R.; Schäfer, Alexandra; Leist, Sarah R. Science, Vol. 373, Issue 6558 https://doi.org/10.1126/science.abi4506	journal	August 2021
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron Carreño, Juan Manuel; Alshammary, Hala; Tcheou, Johnstone Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-022-04399-5	journal	December 2021
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants Yuan, Meng; Huang, Deli; Lee, Chang-Chun D. Science, Vol. 373, Issue 6556 https://doi.org/10.1126/science.abh1139	journal	August 2021
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity Liu, Hejun; Wu, Nicholas C.; Yuan, Meng Immunity, Vol. 53, Issue 6 https://doi.org/10.1016/j.immuni.2020.10.023	journal	December 2020
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain Wheatley, Adam K.; Pymm, Phillip; Esterbauer, Robyn Cell Reports, Vol. 37, Issue 2 https://doi.org/10.1016/j.celrep.2021.109822	journal	October 2021
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph Li, Dinghua; Liu, Chi-Man; Luo, Ruibang Bioinformatics, Vol. 31, Issue 10 https://doi.org/10.1093/bioinformatics/btv033	journal	January 2015
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Liu, Lihong; Iketani, Sho; Guo, Yicheng Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-021-04388-0	journal	December 2021
Broad neutralization of SARS-related viruses by human monoclonal antibodies Wec, Anna Z.; Wrapp, Daniel; Herbert, Andrew S. Science, Vol. 369, Issue 6504 https://doi.org/10.1126/science.abc7424	journal	June 2020
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Garcia-Beltran, Wilfredo F.; Lam, Evan C.; St. Denis, Kerri Cell, Vol. 184, Issue 9 https://doi.org/10.1016/j.cell.2021.03.013	journal	April 2021
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model Rogers, Thomas F.; Zhao, Fangzhu; Huang, Deli Science, Vol. 369, Issue 6506 https://doi.org/10.1126/science.abc7520	journal	June 2020
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses He, Wan-ting; Musharrafieh, Rami; Song, Ge Nature Immunology, Vol. 23, Issue 6 https://doi.org/10.1038/s41590-022-01222-1	journal	June 2022
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Mlcochova, Petra; Kemp, Steven A.; Dhar, Mahesh Shanker Nature, Vol. 599, Issue 7883 https://doi.org/10.1038/s41586-021-03944-y	journal	September 2021
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization Cele, Sandile; Jackson, Laurelle; Khoury, David S. Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-021-04387-1	journal	December 2021
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants Strohl, William R.; Ku, Zhiqiang; An, Zhiqiang BioDrugs, Vol. 36, Issue 3 https://doi.org/10.1007/s40259-022-00529-7	journal	April 2022
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Barnes, Christopher O.; Jette, Claudia A.; Abernathy, Morgan E. Nature, Vol. 588, Issue 7839 https://doi.org/10.1038/s41586-020-2852-1	journal	October 2020
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Planas, Delphine; Saunders, Nell; Maes, Piet Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-021-04389-z	journal	December 2021
Inference of Macromolecular Assemblies from Crystalline State Krissinel, Evgeny; Henrick, Kim Journal of Molecular Biology, Vol. 372, Issue 3 https://doi.org/10.1016/j.jmb.2007.05.022	journal	September 2007
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Cameroni, Elisabetta; Bowen, John E.; Rosen, Laura E. Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-021-04386-2	journal	December 2021
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses Ekiert, D. C.; Friesen, R. H. E.; Bhabha, G. Science, Vol. 333, Issue 6044 https://doi.org/10.1126/science.1204839	journal	July 2011
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Westendorf, Kathryn; Žentelis, Stefanie; Wang, Lingshu Cell Reports, Vol. 39, Issue 7 https://doi.org/10.1016/j.celrep.2022.110812	journal	May 2022
SARS-CoV-2 variants, spike mutations and immune escape Harvey, William T.; Carabelli, Alessandro M.; Jackson, Ben Nature Reviews Microbiology, Vol. 19, Issue 7 https://doi.org/10.1038/s41579-021-00573-0	journal	June 2021
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 Zhou, Tongqing; Wang, Lingshu; Misasi, John Science, Vol. 376, Issue 6591 https://doi.org/10.1126/science.abn8897	journal	April 2022
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice Cohen, Alexander A.; Gnanapragasam, Priyanthi N. P.; Lee, Yu E. Science, Vol. 371, Issue 6530 https://doi.org/10.1126/science.abf6840	journal	February 2021
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV Yuan, Meng; Wu, Nicholas C.; Zhu, Xueyong Science, Vol. 368, Issue 6491 https://doi.org/10.1126/science.abb7269	journal	April 2020
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma Andreano, Emanuele; Piccini, Giulia; Licastro, Danilo Proceedings of the National Academy of Sciences, Vol. 118, Issue 36 https://doi.org/10.1073/pnas.2103154118	journal	August 2021
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody Yin, Wanchao; Xu, Youwei; Xu, Peiyu Science, Vol. 375, Issue 6584 https://doi.org/10.1126/science.abn8863	journal	March 2022
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection Cao, Yunlong; Yisimayi, Ayijiang; Jian, Fanchong Nature, Vol. 608, Issue 7923 https://doi.org/10.1038/s41586-022-04980-y	journal	June 2022
Broad sarbecovirus neutralization by a human monoclonal antibody Tortorici, M. Alejandra; Czudnochowski, Nadine; Starr, Tyler N. Nature, Vol. 597, Issue 7874 https://doi.org/10.1038/s41586-021-03817-4	journal	July 2021
Amino acid substitution matrices from protein blocks. Henikoff, S.; Henikoff, J. G. Proceedings of the National Academy of Sciences, Vol. 89, Issue 22, p. 10915-10919 https://doi.org/10.1073/pnas.89.22.10915	journal	November 1992
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons Rössler, Annika; Riepler, Lydia; Bante, David New England Journal of Medicine, Vol. 386, Issue 7 https://doi.org/10.1056/NEJMc2119236	journal	February 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies Bruel, Timothée; Hadjadj, Jérôme; Maes, Piet Nature Medicine, Vol. 28, Issue 6 https://doi.org/10.1038/s41591-022-01792-5	journal	March 2022
Rational Vaccine Design in the Time of COVID-19 Burton, Dennis R.; Walker, Laura M. Cell Host & Microbe, Vol. 27, Issue 5 https://doi.org/10.1016/j.chom.2020.04.022	journal	May 2020
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape Tregoning, John S.; Flight, Katie E.; Higham, Sophie L. Nature Reviews Immunology, Vol. 21, Issue 10 https://doi.org/10.1038/s41577-021-00592-1	journal	August 2021
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2 Evans, John P.; Zeng, Cong; Qu, Panke Cell Host & Microbe, Vol. 30, Issue 8 https://doi.org/10.1016/j.chom.2022.04.014	journal	August 2022
Tackling COVID-19 with neutralizing monoclonal antibodies Corti, Davide; Purcell, Lisa A.; Snell, Gyorgy Cell, Vol. 184, Issue 12 https://doi.org/10.1016/j.cell.2021.05.005	journal	June 2021
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Dejnirattisai, Wanwisa; Huo, Jiandong; Zhou, Daming Cell, Vol. 185, Issue 3 https://doi.org/10.1016/j.cell.2021.12.046	journal	February 2022
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Garcia-Beltran, Wilfredo F.; St. Denis, Kerri J.; Hoelzemer, Angelique Cell, Vol. 185, Issue 3 https://doi.org/10.1016/j.cell.2021.12.033	journal	February 2022
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody Rappazzo, C. Garrett; Tse, Longping V.; Kaku, Chengzi I. Science, Vol. 371, Issue 6531 https://doi.org/10.1126/science.abf4830	journal	February 2021
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Cao, Yunlong; Wang, Jing; Jian, Fanchong Nature, Vol. 602, Issue 7898 https://doi.org/10.1038/s41586-021-04385-3	journal	December 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351 Gu, Chunyin; Cao, Xiaodan; Wang, Zongda mAbs, Vol. 13, Issue 1 https://doi.org/10.1080/19420862.2021.1930636	journal	January 2021
Antibody evasion properties of SARS-CoV-2 Omicron sublineages Iketani, Sho; Liu, Lihong; Guo, Yicheng Nature, Vol. 604, Issue 7906 https://doi.org/10.1038/s41586-022-04594-4	journal	March 2022
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike Huo, Jiandong; Zhao, Yuguang; Ren, Jingshan Cell Host & Microbe, Vol. 28, Issue 3 https://doi.org/10.1016/j.chom.2020.06.010	journal	September 2020
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity Lucas, Carolina; Vogels, Chantal B. F.; Yildirim, Inci Nature, Vol. 600, Issue 7889 https://doi.org/10.1038/s41586-021-04085-y	journal	October 2021

Similar Records

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

Journal Article · 2023 · Nature Communications · OSTI ID:2423606

Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses

Journal Article · 2023 · Federation of European Biochemical Societies (FEBS) Journal · OSTI ID:2423654

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Journal Article · 2022 · Nature Communications · OSTI ID:1906671

A broad and potent neutralization epitope in SARS-related coronaviruses

Citation Formats

References (52)

Similar Records

Related Subjects